June 2014

Spectranetics Acquires AngioScore

United States - Colorado

In June 2014, The Spectranetics Corporation acquired AngioScore Inc. in a $230 million cash purchase, along with contingent commercial and regulatory milestone payments. FaegreBD's corporate team represented Spectranetics in the deal. The transaction was funded with the proceeds from a $230 million public offering of convertible notes, with FaegreBD advising on the offering.

AngioScore is a leading developer, manufacturer and marketer of cardiovascular specialty balloons based in Fremont, California. The acquisition enhanced Spectranetics' cardiovascular medical device product portfolio and expanded its market opportunities.

Faegre Baker Daniels 网站使用 Cookie 来提升您的浏览体验。